When "normal" isn't. Did you know in #DenseBreasts a "clear/normal" mammo does not reliably mean cancer isn't there? Learn your #breastdensity & talk to your health provider, it may make the difference between an early or late-stage cancer diagnosis. Visit densebreast-info.org

Breast density impacts cancer detection—what should providers and patients know? Join the ACS National Breast Cancer Roundtable webinar on March 26 at 1 PM ET for expert insights on screening, risk, and policy updates. 📅 Register now: ow.ly/GIgG50VhuSh #BreastCancer #DenseBreasts #BreastHealth

Patient safety is always the priority in medical imaging. With IzoView Breast CT, only the breast being imaged receives radiation (at a comparable dose to 2-view mammogram)- the rest of the body, including the chest, is protected thanks to its self-shielding design. No

Have you seen our CEO presentation yet? Watch it here ➡️ loom.ly/ZtIDVYs In this video, we delve into Izotropic's development journey, market potential, strategic plans, and global accessibility. Learn about the imaging capabilities of IzoView, which aims to solve the

The ScreenTrustCAD study shows AI can improve cancer detection in mammograms—a promising step forward! The more cancers we find early, the better. But does AI work equally well for all women, including those with dense breast tissue? What’s missing? 👉 AI enhances cancer

At Izotropic, our mission is to revolutionize breast cancer care by bringing innovative devices like IzoView Breast CT to market. We are working to ensure faster patient access to life-saving technology and to improve outcomes through the earlier and more accurate detection of

Only 37% of mammography referrals from free clinics are completed- a powerful reminder that access remains a major barrier in our healthcare system. Bringing screening directly to patients through mobile clinics and on-site imaging could help close this gap. At Izotropic, we

“I thought the Izotropic- FDA pre-submission discussion was very positive. Given the large number of points for which Izotropic’s approach to the clinical data collection and study design are in alignment with the FDA’s expectations, we were able to focus on a small number of

AI Deemed Unsafe for Independent Breast Cancer Screening in Study of ~10,000 Mammograms: loom.ly/Sn4mQuI ➡️ AI did not detect any cancers that radiologists missed. ➡️ AI missed 8 cancers that radiologists correctly identified. ➡️ AI flagged over 1,000 false-positive

Breast cancer rates are climbing. Diagnoses are expected to rise by 50% and deaths by 12% in the next decade. The burden is falling hardest on younger women and those in countries without access to advanced screening tools. Dedicated breast CT offers a solution. It provides true

"The meeting's purpose was to discuss Izotropic’s recent pre-submission filing and advance the regulatory strategy for its IzoView Breast CT Imaging System. Participants included Izotropic’s executive leadership, technical and engineering teams, medical advisors, FDA and

April is Cancer Prevention and Early Detection Month. Breast cancer screenings save lives. Learn when to get screened and how to take action: cancer.org/cancer/screeni… #BreastCancerAwareness #CancerPrevention #GetScreened #ACSNBCRT

✅ Regulatory alignment with FDA confirmed. ✅ 150-page strategic business plan and advanced financial models completed. ✅ Investor outreach launched to fund clinical execution and market entry. 🔗 loom.ly/KlsJgus $IZO $IZOZF $OTC

📢 Izotropic launches strategic awareness initiatives ahead of IzoView commercialization. New investor-focused platforms, including a podcast and breastCT.com, are in development to support upcoming milestones. 🔗 Read more: izocorp.com/site/assets/fi… #BreastCT

🚨BREAKTHROUGH in breast cancer imaging!🚨 Izotropic’s #IzoView Breast CT system is set to transform the $8.7B market with: ✔️ True 3D scans ✔️ No compression ✔️ 100x MRI spatial resolution ✔️ $500K target price- far less than competitors 🔗 investorwire.com/newsarticle/?q…

📈 Breast imaging is being reshaped by powerful trends: ✔️ AI-powered workflows ✔️ Dense breast screening mandates ✔️ Demand for compression-free, high-res imaging Today, we break down how #IzoView is built to meet these demands and lead the next era of breast cancer detection.

🎙️ Izotropic has launched its brand-new podcast series! In Episode 1, “Beyond the Mammogram: Rethinking the Future of Breast Imaging,” we explore the limitations of traditional screening and the game-changing potential of IzoView’s 3D breast CT technology, especially for women

🌐 Izotropic Launches New Corporate Website & Brand Identity We’re proud to share the launch of our redesigned corporate website and refreshed brand identity, an important milestone as we advance toward commercialization of IzoView, our 3D breast CT imaging system. Our new

🚨 Izotropic Launches BreastCT.com Today, Izotropic unveiled BreastCT.com! A strategic educational platform built to support awareness around breast CT technology and the company’s IzoView imaging system. As IzoView moves toward clinical studies,